Cabaletta Bio Valuation
| CABA Stock | USD 2.10 0.07 3.23% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Cabaletta Bio shows a prevailing Real Value of $4.89 per share. The current price of the firm is $2.1. Our model approximates the value of Cabaletta Bio from analyzing the firm fundamentals such as current valuation of 68.01 M, and Return On Equity of -1.01 as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Cabaletta Bio's price fluctuation is very risky at this time. Calculation of the real value of Cabaletta Bio is based on 3 months time horizon. Increasing Cabaletta Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cabaletta Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cabaletta Stock. However, Cabaletta Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.1 | Real 4.89 | Hype 2.17 | Naive 2.11 |
The real value of Cabaletta Stock, also known as its intrinsic value, is the underlying worth of Cabaletta Bio Company, which is reflected in its stock price. It is based on Cabaletta Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cabaletta Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cabaletta Bio helps investors to forecast how Cabaletta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cabaletta Bio more accurately as focusing exclusively on Cabaletta Bio's fundamentals will not take into account other important factors: Cabaletta Bio Total Value Analysis
Cabaletta Bio is currently forecasted to have valuation of 68.01 M with market capitalization of 202.16 M, debt of 15.6 M, and cash on hands of 96.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cabaletta Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
68.01 M | 202.16 M | 15.6 M | 96.81 M |
Cabaletta Bio Asset Utilization
One of the ways to look at asset utilization of Cabaletta is to check how much profit was generated for every dollar of assets it reports. Cabaletta Bio shows a negative utilization of assets of -0.52 percent, losing $0.005182 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cabaletta Bio shows how unproductive it operates for each dollar spent on its assets.Cabaletta Bio Ownership Allocation
Cabaletta Bio holds a total of 96.27 Million outstanding shares. The majority of Cabaletta Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cabaletta Bio to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cabaletta Bio. Please pay attention to any change in the institutional holdings of Cabaletta Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cabaletta Bio Profitability Analysis
Net Loss for the year was (115.86 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cabaletta Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cabaletta Bio and how it compares across the competition.
About Cabaletta Bio Valuation
The stock valuation mechanism determines Cabaletta Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cabaletta Bio. We calculate exposure to Cabaletta Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cabaletta Bio's related companies.Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |